Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04889911 · ClinicalTrials.gov registry record · NA
Pilot RCT of Self-stigma Treatment for First Episode Psychosis
A NA study of First Episode Psychosis and Youth, sponsored by John Jay College of Criminal Justice, City University of New York.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04889911: Recruiting NA study of First Episode Psychosis and Youth, sponsored by John Jay College of Criminal Justice, City University of New York.
NCT04889911 is a NA study of First Episode Psychosis and Youth that is actively recruiting participants, run by John Jay College of Criminal Justice, City University of New York. The registered enrollment target is 40 participants, below the 6,428-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04889911, a NA study of First Episode Psychosis and Youth, is actively recruiting participants, sponsored by John Jay College of Criminal Justice, City University of New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase treatment engagement. The specific aims of the project are to: 1) adapt NECT to be responsive to the needs and preferences of youth with FEP, and 2) Assess the feasibility, acceptability and preliminary effectiveness of the modified intervention (NECT-YA) combined with coordinated specialty care (CSC) services, compared to CSC services alone, in a small (n = 40) RCT.
Primary Outcome
Quantity of service use will be measured using attendance records for groups collected by facilitators, as well as administrative data on total service use within the FEP programs.
Conditions Studied
Interventions
- BEHAVIORAL Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care
- OTHER Coordinated Specialty Care
Study Locations (1)
Indiana
- Eskenazi Health, PARC Program - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2025-08 |
| Phase | NA |
What NCT04889911 shows while recruiting
NCT04889911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 6,428-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with First Episode Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care is the first listed.
NCT04889911 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04889911 about?
NCT04889911 is a clinical study titled "Pilot RCT of Self-stigma Treatment for First Episode Psychosis". The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase ...
What is the current status of trial NCT04889911?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-01. Estimated completion is 2025-08.
What conditions does trial NCT04889911 study?
This clinical trial studies the following conditions: First Episode Psychosis, Youth.
What interventions are being tested in trial NCT04889911?
The interventions under investigation include: Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care (BEHAVIORAL), Coordinated Specialty Care (OTHER).
Who is sponsoring clinical trial NCT04889911?
This trial is sponsored by John Jay College of Criminal Justice, City University of New York, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04889911 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for First Episode Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04889911's enrollment target sits among peer trials
40 8th of 8 higher than 1 of 8 other First Episode Psychosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other First Episode Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Digital Strategies to Advance Help-Seeking - Aim 3
RECRUITING · NA
-
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
RECRUITING · NA
-
Optimizing Engagement in Services for First-Episode Psychosis
ACTIVE NOT RECRUITING · NA
-
Digital Strategies to Advance Help-Seeking Aim 1 and 2
RECRUITING
-
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
RECRUITING
-
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI